Explore the vast range of titles available.

'Dallas Buyers Club' (Nov. 1): Matthew McConaughey lost a disturbing amount of weight to play Ron Woodruff, a former rodeo cowboy with AIDS who smuggled low-cost and off-brand HIV remedies into the United States in the 1980s.

An engrossing tale of a young woman kept hidden from her mother's killer.

A few years before that, he put Crazy TV Lenny on the shelf, stepping away from doing his own broadcast ads, commercials that made Mattioli a statewide celebrity. [...]he didn't sell them a patio set, he sold them two.

Three different members of the same family passed the baton across the decades in helping care for Camp Randall Stadium, the Field House and finally the Kohl Center. Of getting from the Alumni Association's Arlie Mucks a slab of the Camp Randall bleachers when they were replaced in 1973.

Eighteen-year-old Maria Santos is in the witness protection program until she can testify against her mother's murderer--a man who may have Islamic State group connections.

Mystery UNWILLlNG ACCOMPLlCE: A Munch Mancini Crime Novel BARBARA SERANELLA. Scribner, $24 (304p) ISBN 0-7432-4558-X

Baran reviews \"Dreamtective: The Dreamy and Daring Adventures of Cobra Kite\" by Elizabeth Swados.

Jacobson, Alan. The Hunted. Pocket. Feb. 2001. c.416p. ISBN 0-67102680-1. $24.95. F

Earlier this month, David Graham, an FDA researcher turned whistle-blower, told a congressional panel that Vioxx had caused more than 139,000 heart attacks and strokes, nearly 55,000 of which were deadly. Merck has disputed these numbers, calling them Graham's speculation. JAMA argues that the FDA is too heavily financed and influenced by the drug industry. It said the FDA received $825 million in fees from drugmakers from 1993 to 2003. JAMA also said pharmaceutical companies spent nearly $5 million lobbying the FDA last year. It noted that people on FDA review panels sometimes have stakes in the companies whose drugs they are reviewing. These conflicts are the product of a society that can't decide how much risk it would like to take with new treatments. In the late 1980s, the FDA was under fire for taking too long to approve new drugs. This led to the 1992 Prescription Drug Act, which bolstered the FDA's budget by charging fees to drugmakers.